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Background: We have previously proposed that sensory nerve conduction (SNC) in the median nerve should be
classed as abnormal when the difference between conduction velocities in the little and index fingers is > 8 m/s. In
a prospective longitudinal study, we investigated whether this case definition distinguished patients who were
more likely to benefit from surgical treatment.
Methods: We followed up 394 patients (response rate 56%), who were investigated by a neurophysiology service
for suspected carpal tunnel syndrome. Information about symptoms, treatment and other possible determinants of
outcome was obtained through questionnaires at baseline and after follow-up for a mean of 19.2 months. Analysis
focused on 656 hands with numbness, tingling or pain at baseline. Associations of surgical treatment with
resolution of symptoms were assessed by Poisson regression, and summarised by prevalence rate ratios (PRRs) and
associated 95% confidence intervals (95% CIs).
Results: During follow-up, 154 hands (23%) were treated surgically, and sensory symptoms resolved in 241 hands
(37%). In hands with abnormal median SNC, surgery was associated with resolution of numbness, tingling and pain
(PRR 1.5, 95% CI 1.0-2.2), and of numbness and tingling specifically (PRR 1.8, 95% CI 1.3-2.6). In contrast, no
association was apparent for either outcome when median SNC was classed as normal.
Conclusions: Our definition of abnormal median SNC distinguished a subset of patients who appeared to benefit
from surgical treatment. This predictive capacity gives further support to its validity as a diagnostic criterion in
epidemiological research.
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Diagnosis of carpal tunnel syndrome (CTS) is usually
based on a combination of symptoms, signs and findings
from neurophysiological investigations. Demonstration of
impaired distal sensory nerve conduction (SNC) in the
median as compared with the ulnar or radial nerve is gen-
erally regarded as the most sensitive neurophysiological
marker for the disorder [1]. However, definition of when
median SNC is abnormal has been somewhat arbitrary.* Correspondence: dnc@mrc.soton.ac.uk
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reproduction in any medium, provided the orWe recently examined the relationship of median SNC
to symptoms and signs in a consecutive series of patients,
who were being investigated for suspected CTS at a gen-
eral hospital [2]. Even for the combination of symptoms
and signs which was associated with the greatest mean re-
duction in median SNC, there was overlap of the distribu-
tion of SNC velocities with that in “normal” hands which
had no symptoms or signs. The clearest discrimination
from normal hands was achieved with a cut-point of 8 m/s
for the difference between little and index finger SNC vel-
ocities, and on this basis, we proposed that with the
method of testing employed, a value of > 8 m/s was a rea-
sonable definition for an abnormal difference between
SNC velocities in the little and index fingers (this wouldl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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the index finger was tested, indicating extreme impairment
of conduction).
In the absence of a satisfactory diagnostic gold stand-
ard, the validity of a case definition is best judged by its
practical utility in discriminating categories of illness
which might benefit from different preventive strategies
(i.e. with different risk factors), or different clinical manage-
ment (i.e. with different responses to treatment or progno-
sis) [3]. Using the same case series, we have shown that
our definition of abnormal SNC distinguished patient
groups which differed importantly in their exposures to
risk factors [4]. For example, those with abnormal SNC
had markedly higher body mass index (BMI) than controls,
whereas no association with BMI was apparent for the
group with normal SNC. We here present findings from a
follow-up of the earlier study, in which we examined
whether our definition of abnormal SNC distinguished pa-
tients with different response to surgical treatment.
Methods
The selection and recruitment of patients has been de-
scribed previously [2]. They comprised a consecutive series
of men and women aged 20–64 years, who attended the
neurophysiology department at Southampton General
Hospital during January 2007 to September 2009 for inves-
tigation of suspected CTS.
At baseline and before the results of nerve conduction
studies were known, those who agreed to take part in the
study were asked to complete a self-administered ques-
tionnaire. Among other things, this covered sex, age,
height, weight, smoking habits, somatising tendency, men-
tal health, diabetes, and the occurrence of symptoms
during the past month in each hand (numbness, tingling
and pain) and in the neck (pain). Information on height
and weight was used to derive body mass index (BMI) in
kg/m2. Questions about somatising tendency were taken
from the Brief Symptom Inventory [5], and patients were
classified according to the number of common physical
symptoms from a total of five (faintness or dizziness, pains
in the heart or chest, nausea or upset stomach, trouble
getting breath, and hot or cold spells) that had been at
least moderately distressing in the past week. Mental
health was assessed using questions from the relevant
domain of the Short Form-36 (SF-36) Questionnaire [6],
and scores were grouped to approximate thirds of the dis-
tribution in the study sample (good, intermediate and
poor). Where patients reported numbness or tingling in a
hand, they were asked to mark the anatomical distribution
on a diagram. From this, the distribution was classified
according to whether it included most of the area lying
within the sensory distribution of the median nerve
(“extensive median”), a smaller part of this area (“limited
median”), or only other parts of the hand (“other”) [2].Also at baseline, and again before the results of neuro-
physiological tests were known, a research nurse (CL)
carried out a standardised physical examination of the
hands, which included Tinel’s and Phalen’s tests. Details
of the methods used are reported elsewhere [2].
Nerve conduction studies were carried out by a phy-
sician or clinical physiologist with a Nicolet machine,
according to the normal practice of the department.
Among other things, measurements were made of ortho-
dromic SNC from the index and little fingers to the wrist,
with surface recordings over the median or ulnar nerves
proximal to the distal wrist crease. Median SNC was
deemed to be abnormal if there was no detectable signal
when the index finger was tested, or if the difference in
SNC velocity between the little and the index finger was >
8 m/s.
At the time of completing the baseline questionnaire,
participants were asked whether they would be willing
to receive a follow-up questionnaire. Those who agreed
were sent a further, shorter questionnaire by post after
an interval of approximately 18 months (followed by a
reminder to those who did not respond). This asked
about treatment for hand and arm symptoms since base-
line (surgery on the wrist or hand; injections; and phys-
ical therapy), and about numbness, tingling and pain in
the hands during the past four weeks.
Statistical analysis was carried out with Stata version
11.1 software. As in our earlier report [2], analysis was
based on hands, and was restricted to those which had not
been treated surgically for CTS before baseline. We also
excluded hands in which there had been no numbness,
tingling or pain in the four weeks before the baseline ques-
tionnaire was answered.
For the hands on which follow-up information was
obtained, we first used Poisson regression to explore
baseline predictors of subsequent surgery. To account
for the hierarchical structure of the data, we employed
multi-level modelling, clustering by patient. Associations
were summarised by prevalence rate ratios (PRRs) with
associated 95% confidence intervals (CIs).
Next, we examined the frequency with which symptoms
had resolved by follow-up (i.e. had been absent throughout
the four weeks before answering the follow-up question-
naire) according to baseline characteristics and treatments
received during the follow-up period. Two parallel sets of
multilevel Poisson regression analyses were carried out,
the first with resolution of all sensory symptoms (numb-
ness, tingling and pain) as the outcome, and the second
with resolution of numbness and tingling as the outcome.
The second set of analyses was restricted to hands in
which numbness or tingling had been reported at baseline.
Finally, we compared the association of surgical treat-
ment with symptom resolution according to the presence
or absence of abnormal median SNC and other clinical
Coggon et al. BMC Musculoskeletal Disorders 2013, 14:241 Page 3 of 8
http://www.biomedcentral.com/1471-2474/14/241features at baseline. The statistical significance of differ-
ences in association was quantified by examining the
interaction between the baseline feature and surgical treat-
ment in a regression analysis which took resolution of
symptoms as the dependent variable.
Ethical approval for the study was provided by the
Southampton and South West Hampshire NHS Research
Ethics Committee.Table 1 Number of hands analysed according to
characteristics assessed at baseline
Baseline characteristic
of patient or hand
Hands with symptoms
at baseline
Hands
analysed
All
patients
Agreed to be
followed up
N N N %a %bResults
After exclusion of patients who declined to take part in
the study (27%) and 10 hands that had already been
treated surgically for CTS, our previous analysis was
based on 1806 hands in 905 patients [2]. They included
1506 hands with numbness, tingling or pain in 901 pa-
tients, 704 of whom agreed to receive a follow-up ques-
tionnaire (Figure 1). Among these 704 patients, 394
(56%) completed the follow-up questionnaire, giving a
total of 656 originally symptomatic hands that could be
included in the current analysis (both hands from 262
patients and one hand from 132 patients). Numbness or
tingling had been reported in 633 of the hands atFigure 1 Hands and patients analysed and reasons
for exclusions.baseline, while the other 23 hands had been painful but
without numbness or tingling.
Table 1 shows the numbers of hands analysed according
to characteristics assessed at baseline. Response rates at
follow-up tended to be higher in women than in men, and
at older ages. However, there were no important differ-
ences in the completeness of follow-up data according to
nerve conduction or other clinical findings at baseline.
Among the 394 patients who provided follow-up data, the
mean interval from baseline to follow-up was 19.2 months
(median 18.9, range 15.0 to 31.0, all but four patients be-
tween 17 and 24 months).
In total, 154 hands (23%) had been treated surgically
during the follow-up period, 47 (7%) by injection (of
which 18 were also treated surgically), and 88 (13%) bySex
Male 480 371 180 37.5 48.5
Female 1026 806 476 46.4 59.1
Age (years)
<40 379 269 93 24.5 34.6
40–49 486 382 193 39.7 50.5
50–59 481 395 271 56.3 68.6
≥60 160 131 99 61.9 75.6
Distribution of
numbness/tingling
Other 168 142 80 47.6 56.3
Limited median 392 314 172 43.9 54.8
Extensive median 899 677 381 42.4 56.3
None 47 44 23 48.9 52.3
Tinel’s test
Negative 873 674 371 42.5 55.0
Positive 430 324 192 44.7 59.3
Missing 203 179 93 45.8 52.0
Phalen’s test
Negative 488 376 222 45.5 59.0
Positive 819 626 347 42.4 55.4
Missing 199 175 87 43.7 49.7
Median nerve
sensory conduction
Normal 747 600 322 43.1 53.7
Abnormal 618 474 267 43.2 56.3
Missing 141 103 67 47.5 65.0
a% of all hands with symptoms at baseline.
b% of hands with symptoms at baseline in patients who agreed to receive
follow-up questionnaire.
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cally). The strongest baseline predictor of subsequent
surgery was abnormal median SNC (PRR after adjust-
ment for other risk factors 3.6, 95% CI 2.3-5.5) (Table 2).
After allowance for neurophysiological abnormality, sur-
gery was also more common when Phalen’s test was posi-
tive (PRR 2.4, 95% CI 1.4-4.0). However, associations with
numbness/tingling in an extensive median distribution,
and with positive Tinel’s test, both disappeared after ad-
justment for other predictors.
Overall, 241 hands (37%) were free from pain and
sensory disturbance at the time of follow-up, while the
occurrence of numbness or tingling had resolved in 312
(49%) of the 633 hands in which these symptoms had been
reported at baseline. Table 3 shows the frequency of
symptom resolution in relation to baseline characteristics
and treatment received during follow-up. Resolution ofTable 2 Baseline predictors of carpal tunnel surgery
Risk factor Hands Hands treated by surgery
N N (%) PRRa (95% CI) PRRb (95% CI)
Sex
Male 180 44 24.4 1 1
Female 476 110 23.1 0.9 (0.7–1.3) 1.0 (0.7–1.4)
Age (years)
<40 93 23 24.7 1 1
40–49 193 46 23.8 1.0 (0.6–1.6) 0.8 (0.5–1.4)
50–59 271 61 22.5 0.9 (0.6–1.5) 0.9 (0.6–1.5)
≥60 99 24 24.2 1.0 (0.6–1.7) 0.9 (0.5-1.6)
Distribution of
numbness/
tingling
Other 80 13 16.3 1 1
Limited
median
172 30 17.4 1.1 (0.6–2.1) 0.9 (0.5–1.8)
Extensive
median
381 109 28.6 1.8 (1.0–3.1) 1.2 (0.7–2.1)
None 23 2 8.7 - -
Tinel’s test
Negative 371 64 17.3 1 1
Positive 192 68 35.4 2.1 (1.5–2.9) 1.2 (0.8–1.7)
Missing 93 22 23.7 - -
Phalen’s test
Negative 222 20 9.0 1 1
Positive 347 112 32.3 3.6 (2.2–5.8) 2.4 (1.4–4.0)
Missing 87 22 25.3 - -
Median sensory
nerve conduction
Normal 322 27 8.4 1 1
Abnormal 267 101 37.8 4.5 (3.0–6.9) 3.6 (2.3–5.5)
Missing 67 26 38.8 - -
aEach risk factor analysed independently.
bAll risk factors analysed in a single regression model.symptoms was unrelated to sex or age, but was more fre-
quent in patients treated by surgery (PRR 1.4 for both out-
comes). After allowance for these variables, it was less
likely in current smokers (PRR 0.7 for both outcomes) and
in patients with a strong tendency to somatise (PRR 0.7
for both outcomes). In addition, complete resolution of
sensory symptoms, including pain as well as numbness
and tingling, was less common when neck pain was
reported at baseline (PRR 0.7, 95% CI 0.6-0.9) and
more common in patients with diabetes (PRR1.6,
95% CI 1.0-2.5), while numbness and tingling were less
likely to resolve when BMI was ≥30 kg/m2 (PRR 0.7,
95% CI 0.5-1.0).
Table 4 compares associations between symptom reso-
lution and surgical treatment according to clinical features
assessed at baseline. Risk estimates are presented with and
without adjustment for the five risk factors in Table 3
which showed significant (p < 0.05) associations with reso-
lution of symptoms (smoking habits, somatising tendency,
neck pain, diabetes and BMI). The adjustment had only a
small impact. Among patients with abnormal median
SNC, surgery was associated with resolution both of
numbness, tingling and pain (adjusted PRR 1.5, 95% CI
1.0-2.2) and of numbness and tingling specifically (adjusted
PRR 1.8, 95% CI 1.3-2.6). In contrast, no association with
surgery was apparent for either outcome where median
SNC was classed as normal. Similarly, there was evidence
of a differential outcome after surgery where numbness
and tingling were originally present in regions of the hand
falling exclusively within the sensory distribution of the
median nerve. However, negative findings from bothTinel’s
and Phalen’s tests did not preclude a better outcome in pa-
tients treated surgically. The difference in associations be-
tween surgery and resolution of numbness and tingling
according to median SNC abnormality was of borderline
statistical significance (p = 0.05).
Discussion
In this follow-up investigation, the definition of abnor-
mal median SNC that we had previously proposed dis-
tinguished a group of patients which appeared to benefit
from surgery from another which did not. This further
supports the utility of the definition as a diagnostic cri-
terion in epidemiological research.
In longitudinal studies, the response rate most relevant
to internal validity is that among subjects who enter
follow-up – in our study, patients who consented at base-
line to receive a second questionnaire. The response rate
that we were able to achieve (56% overall) was less than
ideal, and as in many studies, was lower in men and at
younger ages. Nevertheless, important bias would have
resulted only if responders were atypical as regards the re-
lation of baseline characteristics to outcomes of interest –
principally the resolution of numbness, tingling and pain,
Table 3 Frequency of symptom resolution in hands according to baseline characteristics and treatment during follow-up
Predictor Pain, numbness or tingling Numbness or tingling
No. at
baseline
Symptoms resolved at follow-up No. at
baseline
Symptoms resolved at follow-up
N (%) PRRa (95% CI) N (%) PRRa (95% CI)
Sex
Male 180 72 40.0 1 176 90 51.1 1
Female 476 169 35.5 0.9 (0.7–1.2) 457 222 48.6 0.9 (0.7–1.2)
Age (years)
<40 93 35 37.6 1 91 46 50.5 1
40–49 193 66 34.2 0.9 (0.6–1.3) 192 85 44.3 0.9 (0.6–1.3)
50–59 271 110 40.6 1.1 (0.7–1.6) 256 144 56.3 1.1 (0.8–1.6)
≥60 99 30 30.3 0.8 (0.5–1.3) 94 37 39.4 0.8 (0.5–1.2)
Treated by surgery
No 502 170 33.9 1 481 216 44.9 1
Yes 154 71 46.1 1.4 (1.0–1.8) 152 96 63.2 1.4 (1.1–1.8)
Treated by injection
No 609 230 37.8 1 587 293 49.9 1
Yes 47 11 23.4 0.6 (0.3–1.1) 46 19 41.3 0.8 (0.5–1.2)
Treated by physical therapy
No 568 211 37.1 1 546 275 50.4 1
Yes 88 30 34.1 0.9 (0.6–1.3) 87 37 42.5 0.8 (0.6–1.2)
BMI
<25 201 72 35.8 1 191 107 56.0 1
≥25 and <30 228 90 39.5 1.1 (0.8–1.5) 221 109 49.3 0.8 (0.6–1.1)
≥30 211 75 35.5 0.9 (0.7–1.3) 205 90 43.9 0.7 (0.5–1.0)
Missing 16 4 25.0 0.6 (0.2–1.7) 16 6 37.5 0.6 (0.3–1.3)
Smoking
Never 313 122 39.0 1 302 163 54.0 1
Ex- 213 79 37.1 0.9 (0.7–1.2) 208 101 48.6 0.8 (0.6–1.1)
Current 122 36 29.5 0.7 (0.5–1.0) 115 44 38.3 0.7 (0.5–1.0)
Missing 8 4 50.0 1.3 (0.5–3.5) 8 4 50.0 1 (0.4–2.6)
Neck pain
No 302 132 43.7 1 291 156 53.6 1
Yes 354 109 30.8 0.7 (0.6–0.9) 342 156 45.6 0.9 (0.7–1.1)
Number of distressing somatic symptoms
0 141 62 44.0 1 138 76 55.1 1
1 192 75 39.1 0.9 (0.6–1.3) 181 104 57.5 1.1 (0.8–1.4)
≥2 323 104 32.2 0.7 (0.5–1.0) 314 132 42.0 0.7 (0.6–1.0)
Mental health
Good 226 76 33.6 1 218 98 45.0 1
Intermediate 200 79 39.5 1.2 (0.9–1.6) 193 101 52.3 1.2 (0.9–1.5)
Poor 225 81 36.0 1.1 (0.8–1.5) 217 108 49.8 1.1 (0.9–1.5)
Missing 5 5 100.0 3.2 (1.3–7.9) 5 5 100.0 2.3 (0.9–5.6)
Diabetes
No 616 217 35.2 1 593 288 48.6 1
Yes 40 24 60.0 1.6 (1.0–2.5) 40 24 60.0 1.1 (0.7–1.8)
aEach predictor analysed independently with adjustment for sex, age and surgical treatment.
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Table 4 Frequency of symptom resolution in hands treated or not treated by surgery according to clinical features
assessed at baseline
Clinical feature Numbness, tingling or pain Numbness or tingling
No surgery Surgery No surgery Surgery
N (%)
resolved
N (%)
resolved
PRRa PRRb N (%)
resolved
N (%)
resolved
PRRa PRRb
(95% CI) (95% CI) (95% CI) (95% CI)
Distribution of numbness/tingling
Other 22 (32.8) 2 (15.4) 0.5 (0.1–2.0) 0.6 (0.1–2.5) 31 (46.3) 6 (46.2) 1.0 (0.4–2.4) 1.2 (0.5–3.0)
Limited median 52 (36.6) 17 (56.7) 1.5 (0.9–2.7) 1.7 (0.9–3.1) 69 (48.6) 20 (66.7) 1.4 (0.8–2.3) 1.5 (0.9–2.6)
Extensive median 89 (32.7) 52 (47.7) 1.5 (1.0–2.1) 1.4 (1.0–2.1) 116 (42.6) 70 (64.2) 1.5 (1.1–2.0) 1.6 (1.1–2.2)
Tinel’s and Phalen’s tests
Both negative 70 (39.1) 12 (63.2) 1.6 (0.9–3.0) 1.5 (0.8–2.7) 82 (50.3) 14 (77.8) 1.5 (0.9–2.7) 1.4 (0.8–2.6)
At least one positive 80 (31.4) 53 (46.5) 1.5 (1.0–2.1) 1.4 (1.0–2.0) 106 (42.1) 74 (65.5) 1.6 (1.2–2.1) 1.6 (1.1–2.1)
Missing 20 (29.4) 6 (28.6) 1.0 (0.4–2.4) 0.9 (0.3–2.5) 28 (42.4) 8 (38.1) 0.9 (0.4–2.0) 0.9 (0.4–2.1)
Median nerve sensory conduction
Normal 93 (31.5) 8 (29.6) 0.9 (0.5–1.9) 0.9 (0.4–1.9) 129 (46.1) 9 (34.6) 0.8 (0.4–1.5) 0.8 (0.4–1.6)
Abnormal 57 (34.3) 51 (50.5) 1.5 (1.0–2.1) 1.5 (1.0–2.2) 67 (41.1) 72 (72.0) 1.8 (1.3–2.4) 1.8 (1.3–2.6)
Missing 20 (48.8) 12 (46.2) 0.9 (0.5–1.9) 1.4 (0.6–3.3) 20 (52.6) 15 (57.7) 1.1 (0.6–2.1) 1.6 (0.7–3.6)
All hands 170 (33.9) 71 (46.1) 1.4 (1.0–1.8) 1.3 (1.0–1.7) 216 (44.9) 96 (63.2) 1.4 (1.1–1.8) 1.4 (1.1–1.8)
aUnadjusted.
bAdjusted for BMI, smoking habits, neck pain, number of distressing somatic symptoms and diabetes at baseline.
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ied little according to clinical findings at baseline (Table 1)
makes it unlikely that associations between symptom reso-
lution and surgery would be biased differentially in rela-
tion to these clinical features.
A greater challenge to interpretation is the possibility
of confounding by factors influencing selection for sur-
gery. Although randomised controlled trials attest to
the benefit of surgical decompression of the carpal tun-
nel in CTS [7], the associations which we observed be-
tween surgical treatment and symptom resolution may
not fully reflect the impact of surgery. It could be, for
example, that a decision was taken not to operate on
some patients because their symptoms were already im-
proving spontaneously, in which case the benefits of
surgery would tend to be underestimated in our ana-
lysis. To minimise the potential for such confounding,
we adjusted for risk factors at baseline which were iden-
tified as carrying an adverse prognosis independent of
surgical treatment, and reassuringly, this adjustment
had only minor impact on the risk estimates of main
interest. We cannot rule out a residual effect of other,
unrecognised confounders, but to produce important
bias in relation to our study question, such confounding
would have to be differential according to baseline
nerve conduction results, which seems unlikely. In par-
ticular, there is no reason to expect that surgeons would
be more likely to operate on patients with a poorer
chance of responding to surgery if they had normal as
compared with abnormal median nerve conduction.Another limitation was the modest statistical power to
demonstrate differences in associations of symptom
resolution with surgery according to baseline character-
istics. Thus although surgery was clearly associated with
the disappearance of symptoms in hands with abnormal
median SNC, and there was no indication of any benefit
from surgery in those with normal median SNC, this di-
vergence was only of borderline statistical significance.
That said, our investigation was larger than most previ-
ously reported studies of outcome following surgery for
CTS [8], and had the advantage of referent data from
patients who were not treated surgically.
As would be expected, abnormality of median SNC
was a strong predictor of surgical treatment (PRR 3.6,
95% CI 2.3-5.5). However, surgery was by no means lim-
ited to hands with abnormal median SNC according to
our definition. This is not surprising since the definition,
which was proposed for use in epidemiological studies
and not in clinical practice, was formulated only after
the collection of all baseline data for the study was
complete. Moreover, it did not take account of other
neurophysiological findings – for example, on motor
nerve conduction. The importance of other clinical fea-
tures is evidenced in the higher rate of surgery when
Phalen’s test was positive, even after account was taken
of whether median SNC was abnormal (Table 2).
After allowance for any surgical treatment, symptom
resolution was less frequent in current smokers and in
patients who tended to somatise. An adverse prognostic
influence of smoking has not been reported previously,
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sistence of musculoskeletal pain in other circumstances
[9,10], presumably because it increases patients’ awareness
of, and causes them to dwell on, symptoms which others
would dismiss. Complete resolution of sensory symptoms
was also less likely in patients who reported neck pain at
baseline, perhaps because in some of these patients, hand
symptoms were attributable to pathology in the neck that
was less likely to improve over time. In contrast, diabetes
was associated with higher resolution of symptoms. In
addition, numbness and tingling resolved less frequently
in patients with high BMI. Obesity is a known risk factor
for CTS [11-16], but has not been clearly associated with
worse outcome following surgery [17]. The comparisons
that we made of associations between surgery and symp-
tom resolution were all carried out with and without ad-
justment for these prognostic variables.
Although many studies have examined outcomes after
surgery for CTS according to pre-operative neurophysio-
logical findings [18-35], these have not entailed compari-
sons with patients who had similar neurophysiological
results but were not treated surgically. Thus, they do not
allow assessment of the extent to which improvements
in symptoms could be attributed to surgery, or of
whether patients with particular neurophysiological ab-
normalities benefitted more from surgical treatment. Be-
cause of limited statistical power and the possibility of
uncontrolled residual confounding, we cannot draw firm
conclusions on this second question. However, our re-
sults support the hypothesis that abnormal median SNC,
as we have defined it, distinguishes hands that are more
likely to benefit from surgical decompression of the car-
pal tunnel. They also suggest that surgery is unlikely to
be of value when numbness and tingling do not affect
any parts of the hand that lie exclusively within the sen-
sory distribution of the median nerve. In contrast, when
both Tinel’s and Phalen’s tests were negative, there was
still an apparent benefit from surgical treatment.
Conclusions
We have already demonstrated that our proposed definition
of abnormal median SNC distinguished disease with dis-
tinctive risk factors [4]. That it appears also to predict bene-
fit from surgical treatment gives further support to its
validity as a diagnostic criterion in epidemiological research.
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